Stockreport

Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis [Yahoo! Finance]

Amylyx Pharmaceuticals, Inc.  (AMLX) 
PDF CAMBRIDGE, Mass., April 09, 2025 BUSINESS WIRE Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) ("Amylyx" or the "Company") today announced that the first participant has be [Read more]